Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytokinetics
Reports highlight recent developments from Cytokinetics
February 14th, 2007
Reports highlight recent developments from Cytokinetics. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cytokinetics. Report 1: Cytokinetics, Incorporated (CYTK) announced that a poster summarizing non-clinical data evaluating ispinesib (SB-715992), a novel inhibitor of the mitotic kinesin, kinesin spindle protein (KSP), in cellular models of multiple myeloma was presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida. A poster entitled, "Inhibition of Kinesin Spindle Protein Induces Apoptosis and Overcomes Drug Resistance in Models...
Source: Medical Patent Law Weekly (2007-02-14)
|
